Andrea Necchi Selected Research

Andrea Necchi Research Topics

Disease

92	Neoplasms (Cancer) 10/2022 - 08/2009
87	Carcinoma (Carcinomatosis) 10/2022 - 10/2012
59	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 08/2015
34	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2013
24	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2021 - 01/2010
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 11/2009
16	Penile Neoplasms (Penile Cancer) 05/2022 - 01/2015
15	Disease Progression 10/2022 - 02/2015
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2015
7	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 01/2020
7	Seminoma 10/2021 - 06/2016
6	Non-Muscle Invasive Bladder Neoplasms 05/2022 - 01/2018
5	Microsatellite Instability 12/2021 - 01/2019
4	Urologic Neoplasms (Urological Cancer) 04/2022 - 10/2019
4	Lymphatic Metastasis 01/2021 - 01/2015
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 12/2018
3	Pathologic Complete Response 01/2021 - 01/2019
3	Testicular Neoplasms (Testicular Cancer) 01/2020 - 10/2011
3	Adenocarcinoma 01/2020 - 04/2011
3	Nonseminomatous germ cell tumor 11/2019 - 10/2016
2	Carcinoma in Situ 09/2022 - 01/2017
2	Pneumonia (Pneumonitis) 12/2020 - 05/2016
2	Neutropenia 12/2020 - 01/2020
2	Pain (Aches) 11/2020 - 11/2015
2	Lymphadenopathy 01/2020 - 01/2020
2	Residual Neoplasm 12/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

36	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 11/2010
35	PlatinumIBA 01/2022 - 08/2012
26	Immune Checkpoint InhibitorsIBA 04/2022 - 05/2016
23	pembrolizumabIBA 03/2022 - 09/2016
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2016
8	atezolizumabIBA 03/2022 - 05/2016
7	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
6	B7-H1 AntigenIBA 01/2022 - 01/2017
6	erdafitinibIBA 01/2022 - 01/2019
6	Monoclonal AntibodiesIBA 01/2022 - 09/2016
6	Biological ProductsIBA 12/2021 - 11/2009
6	NivolumabIBA 12/2020 - 09/2016
5	RamucirumabIBA 01/2022 - 11/2017
5	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2019
5	Etoposide (VP 16)FDA LinkGeneric 10/2021 - 06/2016
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021 - 02/2019
5	AlbuminsIBA 01/2018 - 05/2014
5	Gemcitabine FDA Link 01/2018 - 02/2014
5	taxaneIBA 01/2017 - 01/2016
4	Pharmaceutical PreparationsIBA 10/2022 - 08/2012
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2015
4	Docetaxel (Taxotere)FDA Link 11/2020 - 01/2017
3	Carboplatin (JM8)FDA LinkGeneric 06/2022 - 01/2017
3	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2021
3	enfortumab vedotinIBA 01/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 11/2015
3	Tumor Biomarkers (Tumor Markers)IBA 06/2021 - 11/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 06/2016
3	durvalumabIBA 12/2020 - 01/2019
3	tremelimumabIBA 12/2020 - 01/2019
3	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2020 - 02/2016
3	LigandsIBA 01/2018 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 06/2014
3	Taxoids (Taxanes)IBA 04/2016 - 06/2015
3	pazopanib FDA Link 02/2016 - 08/2012
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2021
2	CreatinineIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2015
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 11/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 01/2019
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 11/2017
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2017
2	cyclopropapyrroloindoleIBA 11/2019 - 01/2018
2	Therapeutic UsesIBA 10/2019 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 11/2015
2	AntibodiesIBA 01/2018 - 01/2018
2	Aurora Kinase AIBA 01/2017 - 04/2016
2	MLN 8237IBA 01/2017 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 12/2016 - 01/2016
2	Brentuximab VedotinIBA 09/2016 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015 - 06/2014
2	Vinblastine (Vinblastine Sulfate)FDA Link 08/2015 - 06/2014

Therapy/Procedure

95	Drug Therapy (Chemotherapy) 06/2022 - 08/2009
65	Therapeutics 09/2022 - 08/2011
38	Immunotherapy 05/2022 - 09/2016
37	Cystectomy 09/2022 - 08/2015
30	Neoadjuvant Therapy 10/2022 - 08/2015
25	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 10/2011
19	Adjuvant Chemotherapy 06/2022 - 01/2015
10	Nephroureterectomy 10/2022 - 01/2017
10	Salvage Therapy 01/2021 - 06/2011
4	Radiotherapy 05/2022 - 12/2012
4	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 04/2016
4	Orchiectomy (Orchidectomy) 06/2021 - 12/2012
3	Transplantation 01/2018 - 03/2016
2	Adjuvant Radiotherapy 11/2022 - 01/2018
2	Operative Surgical Procedures 01/2022 - 10/2021
2	Castration 01/2022 - 10/2021
2	Nephrectomy 12/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2021 - 01/2017
1	Conservative Treatment 09/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022